Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous adipose-derived stem cell application for facial skin aging
RBR-2nn9y2Phase 1Completed
- Sponsor
- Federal University of Rio de Janeiro
- Start
- Aug 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of autologous adipose-derived mesenchymal stromal cells in photoaging, sponsored by Federal University of Rio de Janeiro. Primary endpoint: Cutaneous analysis after adipose-derived stem cell application. Started Aug 2012; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
photoaging
Beyond the preview
Go deeper on RBR-2nn9y2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2nn9y2.